Impact of universal hepatitis b vaccination on antenatal hepatitis b prevalence in the midlands region of the north island, New Zealand

New Zealand Medical Journal

Volumn 124, Issue 1332, 2011, Pages 40-44

  Addidle, Michael ^a  

^a Clinical Microbiologist   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HEPATITIS B; HUMAN; INFANT; MALE; NEW ZEALAND; OUTCOME ASSESSMENT; PREVALENCE; TREND STUDY; VACCINATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INCIDENCE; MASS VACCINATION; NEW ZEALAND; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79955414017     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Ministry of Health. New Zealand Immunisation Handbook 2006, Chapter 3.
2. Robinson T, Buller C, Humphries W, et al. The New Zealand Hepatitis B Screening Programme: Screening coverage and prevalence of chronic Hepatitis B infection, New Zealand Medical Journal 2005, 118.
3. Milne A., Allwood GK, Moyes CD, et al. Prevalence of hepatitis B infections in a multiracial New Zealand community. NZ Medical Journal.1985;98:529-32.
4. Miller JA, Hermon YE. Hepatitis B in pregnant women. NZ Medical Journal.1984;97:461.
5. Lin HC, Liu CC, Huang SE, et al. Impact of Universal Hepatitis B Vaccination on the Prevalence of HBs and HBe Antigenemia Among Pregnant Women in Taiwan. International Journal of Infectious Diseases. December 2008;12:supplement 1:e95-e96.
6. Dawar M, Patrick DM, Bigham M, et al. Impact of universal preadolescent vaccination against hepatitis B an antenatal seroprevalence of hepatitis B markers in British Columbia. CMAJ 2003;168(6):703-704.
7. Bonanni P, Pesavento G, Bechini A, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003;21;issues 7-8:685-691.
8. National serosurvey of vaccine preventable diseases 2009. www.moh.govt.nz/moh.nsf/indexmh/national-serosurvey-of-vaccine-preventable-diseases-may09.ISBN 978-0-478-31924-8.